We recently hosted our annual alternative data conference in London and invited two legal experts to discuss the compliance and regulatory developments related to alternative data in the UK and Europe versus the US. The following article highlights the key takeaways from this discussion. Sonalini de Zoysa Gunasekera, Legal Counsel at Systematica Investments, and Anna Maleva-Otto, Partner at Schulte Roth + Zabel LLP joined to discuss the complexities surrounding the current state of alternative data compliance and regulation happening in Europe and the UK as opposed to the US. The panelists covered a wide array of topics, including adequate due diligence, material non-public information (MNPI) nuances, regulatory focus in different jurisdictions, technological advancements, and the increased risks related to using alternative datasets.
Investing in energy markets can encompass a wide range of opportunities, including traditional fossil fuels, renewable energy, energy infrastructure, and related technologies. Historically, investments in oil and gas exploration and production have generated substantial returns during periods of high oil prices, especially during the price spikes of the 1970s and early 2000s. However, macro effects during those periods were not similar.
San Juan, Puerto Rico, September 7th, 2023 – Gulp Data, the leader in data-backed loans, and Eagle Alpha, a leading provider of alternative data solutions to buyers and vendors, today announced their partnership to ensure that business owners have more ways to monetize their data and access fast, dilution-free funding.
Investing in technology involves unique challenges and opportunities. The sector often commands higher valuations, reflecting its above-average growth potential. Yet, even unprofitable tech companies can hold huge valuations, demanding careful consideration of company details, product offerings, and competitive landscapes. Technology companies are also associated with continuous innovation and considerable expenditures on R&D projects.
In just two years (2019-2021), VC companies globally pumped more than $52 billion into therapeutic-based biotech companies, with a significant chunk dedicated to start-ups armed with platform technologies. The investment pattern suggests a strong inclination towards ground-breaking technologies capable of delivering personalized treatments to patients with enhanced precision. Precision medicine serves as a perfect example, offering the ability to diagnose conditions sooner and providing tailored therapies aligned with patients’ unique genetic profiles.
The use of alternative data by these funds has also grown throughout the years as they feature in our latest buyside surveys. COVID-19, government lockdowns, and supply chain disruption also created a significant challenge to company and economic forecasting models which led to higher demand for inflation, pricing, and supply chain insights.
Data compliance has always been an important subject, however, there have been several key events that have paved the way toward where we are today. We are now seeing regulators proactively examining firms’ policies and procedures with more intent. Data sources considered higher risk than others are now found in the regulatory and media spotlight, and varying regional regulations are impacting the funds’ global strategies.
In today’s globalized world, economic conditions are constantly changing. That is why accurate and early forecasts of global trade flows can provide a good read on economic activity both at the macro and micro levels.
Eagle Alpha Announces Release of Surveyor – The Leading Compliance Workflow Product for Data Vendor Monitoring and Communication Capture
Eagle Alpha is excited to announce the release of ‘Surveyor by Eagle Alpha’, a compliance-focused product to support data buyers and data vendors with due diligence and communication capture.
New industries are typically fragmented with numerous small players competing for market share. Industries then consolidate as they become more mature. According to A.T. Kearney’s study, all industries go through a consolidation life cycle which consists of five stages – opening, plateau, concentration, dominance, and reopening. Every company in every industry goes through these stages or disappears. Increased competition, changing regulations, new technologies, and increasing customer sophistication is putting pressure on today’s technology leaders and alternative data vendors. Companies would mostly pursue mergers and acquisitions to gain scale advantages and accelerate growth. A size advantage often lowers costs leading to competitive advantage and to competitive price setting.